Bioglutide
Characteristics
- Chemical Name: Bioglutide (reported research designation; limited publicly standardized nomenclature)
- Other Name(s): Long-acting GLP-1 receptor agonist (reported); peptide incretin analog (research context)
- CAS: Not publicly established / not consistently reported
- Powder Purity: ≥ 98% (HPLC)
- Solubility: Soluble in water and aqueous buffers (e.g., PBS); solubility dependent on pH and formulation conditions
- Molar Mass: ~ Not definitively published (expected in peptide range ~3,500–5,000 g/mol based on class)
- Chemical Formula: Pending
- Shelf Life: Up to 24 months when stored lyophilized at −20 °C or below, protected from light and moisture
- Appearance: White to off-white lyophilized powder
- Biological Half-Life: Not well established; expected to be extended relative to native GLP-1 (design-dependent, often via albumin binding or peptide modification)
- Safety Compliance:
- Not approved for human or animal consumption
- Not intended for diagnostic, therapeutic, or clinical use
- Handle by trained professionals using appropriate laboratory safety procedures
Description
Bioglutide is described in research as a synthetic peptide designed to act as a glucagon-like peptide-1 (GLP-1) receptor agonist, targeting pathways involved in appetite regulation, insulin secretion, and metabolic control. However, unlike well-characterized compounds such as Semaglutide or Tirzepatide, publicly available scientific data on Bioglutide is extremely limited.
There are no robust peer-reviewed clinical trials, standardized chemical disclosures, or regulatory approvals associated with this compound as of now. Most references appear in research chemical listings rather than formal pharmaceutical literature, which means:
- Its exact structure and pharmacology are not fully verified
- Safety, dosing, and long-term effects are unknown
- Quality and consistency may vary significantly between sources
Because of this, Bioglutide is considered an experimental peptide, and any use should be restricted strictly to controlled laboratory research settings.







